Assessment of the quality of life of patients with ankylosing spondylitis based on the results of the HAQ and HAQ-S questionnaires

The purpose of the study was to study the effect of various types of treatment for ankylosing spondylitis on the quality of life of patients. The results of a study of the quality of life (according to the HAQ and HAQ-S questionnaire) of 74 adult patients with AS under the influence of treatment with NSAIDs, sulfasalazine, methotrexate, and adalimumab 3, 6, and 12 months after treatment are presented. It was found that patients with AS at all stages of therapy showed an improvement in quality of life indicators according to the HAQ and HAQ-S questionnaires in the 2nd and 4th groups of patients with AS who took sulfasalazine and adalimumab.